SD
Samiran Dutta
About Samiran Dutta
Samiran Dutta has 19 years in corporate governance. Holds Director role. Formerly with 7 companies, such as Plus Patient Remedies (India) Limited and Skaipher Nutraceutical Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Plus Patient Remedies (India) Limited
U24232WB2007PLC116414
|
Director | 12 Jun 2007 | 2007 | Active |
Skaipher Nutraceutical Limited
U24100WB2015PLC208673
|
Ceo(Kmp) | 08 Dec 2015 | 2015 | Active |
Orepher Infotech Private Limited
U55101WB2012PTC182037
|
Additional Director | 21 Sep 2012 | 2012 | Strike Off |
Flipzone Lifestyle Private Limited
U93000WB2013PTC193077
|
Additional Director | 10 Jun 2013 | 2013 | Strike Off |
Oripher Lifestyle Limited
U55101WB2012PLC181848
|
Additional Director | 17 Oct 2012 | 2012 | Strike Off |
Plus Developer Private Limited
U51909WB2011PTC165889
|
Director | 04 Aug 2011 | 2011 | Strike Off |
Max Remedies India Limited
U24233UP2011PLC047145
|
Director | 24 Oct 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samiran Dutta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samiran Dutta
Samiran Dutta has 19 years in corporate governance. Holds Director role. Formerly with 7 companies, such as Plus Patient Remedies (India) Limited and Skaipher Nutraceutical Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Samiran Dutta is associated with 0 companies as Director.
Samiran Dutta has expertise in General Business, Technology.
Samiran Dutta has 19 years in corporate governance.